Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Outcome study of oral bedaquiline-based regimens for drug-resistant tuberculosis in children and adolescents
PACTR202505474141640Not yet recruiting
- Sponsor
- Institute of Human Virology Nigeria
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of bedaquiline in Tuberculosis (TB), sponsored by Institute of Human Virology Nigeria. Primary endpoint: Successful or unsuccessful treatment outcomes. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
bedaquiline
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on PACTR202505474141640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202505474141640.